Coatings and Surface Treatment Supplier Controls for Medical Devices: Qualification, Validation, and Quality Agreement Strategy

Why Coatings and Surface Treatments Are a Supplier Control Problem

Surface treatments occupy a unique position in the medical device supply chain. The coating or treatment is typically one of the last manufacturing steps before final assembly or sterilization, and it fundamentally alters the device's surface properties — corrosion resistance, wear resistance, friction coefficient, biocompatibility, and dimensional characteristics. A failed coating is not a cosmetic defect. On a surgical instrument, it means corrosion in the autoclave. On an orthopedic implant, it means metal ion release into the patient. On a catheter, it means increased friction during insertion.

Unlike a machined component where you can measure every dimension on every part, coatings are thin (often 1–10 µm), applied in batch processes, and their critical properties — adhesion, density, phase composition, residual stress — cannot be verified on every part without destroying it. This makes surface treatment a special process under ISO 13485 Clause 7.5.6, the same category as sterilization and adhesive bonding.

Most medical device OEMs do not perform their own coatings. They send parts to external coating suppliers — job shops, specialty coaters, or large service providers — and receive finished parts back. The OEM owns the design and the regulatory responsibility, but the supplier controls the process. This creates a supplier quality challenge that is qualitatively different from buying a commodity component: you are outsourcing a validated process, not buying a part to a drawing.

This article covers how to qualify, validate, control, and monitor coatings and surface treatment suppliers under the current regulatory framework — FDA QMSR (effective February 2, 2026), ISO 13485:2016, and EU MDR 2017/745.

The Surface Treatment Landscape for Medical Devices

Passivation

Passivation is the chemical removal of free iron from the surface of stainless steel and the promotion of a uniform chromium oxide passive layer. It is the most fundamental surface treatment for medical devices made from austenitic stainless steel (304, 316L, 316LVM), cobalt-chromium alloys, titanium, and nickel-based alloys.

The governing specifications are ASTM A967 (standard specification for chemical passivation treatments for stainless steel parts), AMS 2700 (replacement for the legacy QQ-P-35), and ASTM F86 (surface preparation and marking of metallic surgical implants). For titanium and titanium alloys specifically, ASTM F86 and ASTM B600 address cleaning and descaling.

Passivation is a relatively simple chemical process — immersion in nitric acid or citric acid solutions at controlled temperature and time — but it is process-sensitive. Inadequate passivation leaves free iron on the surface, which becomes an initiation site for corrosion. Over-aggressive passivation can etch precision surfaces and change dimensions on tightly toleranced features. The choice between nitric acid and citric acid methods affects both process control and environmental compliance; citric acid is increasingly preferred for its safer handling and waste profile.

Passivation does not add measurable thickness. The dimensional impact is minimal, but cleaning, pickling, or descaling steps in the passivation workflow can affect surface roughness on precision sealing surfaces.

Anodizing

Anodizing is an electrochemical conversion process that grows a controlled aluminum oxide layer on aluminum and aluminum alloys. In medical devices, anodized aluminum is used for surgical instrument cases and trays, handles, endoscopic components, and craniomaxillofacial hardware.

Standard sulfuric acid anodizing (Type II, per MIL-A-8625) produces coatings of 5–25 µm. Hard coat anodizing (Type III) produces coatings up to 50+ µm with significantly improved wear resistance. Both types can be dyed for color coding and identification.

Medical device anodizing has tighter process control requirements than general industrial anodizing. The coating must withstand repeated autoclave cycles without chipping, crazing, or color change. Specialized coatings like MICRALOX (a proprietary micro-crystalline anodic coating) have been developed specifically for the medical market to address the autoclave durability problem that conventional anodized coatings exhibit.

Anodizing adds measurable thickness — typically half above and half below the original surface. On precision-machined features, the OEM must account for this dimensional change in the pre-finish machining specifications. A common approach is to specify "machine to pre-finish dimensions per supplier process plan" and require that final critical dimensions meet the drawing after finishing.

Physical Vapor Deposition (PVD)

PVD coatings are thin-film coatings deposited in a vacuum chamber by vaporizing a solid source material and condensing it onto the substrate. The dominant PVD coating types in medical devices:

• Titanium Nitride (TiN): The gold-colored coating. The highest-volume PVD coating in the medical device industry since the late 1980s. Used on surgical instruments for wear resistance, identification, and aesthetic differentiation. Hardness approximately 2,300 HV.

• Titanium Carbonitride (TiCN): Bluish-gray, higher hardness than TiN (~3,000 HV). Used on cutting instruments where edge retention is critical.

• Chromium Nitride (CrN): Silver-colored, excellent corrosion resistance. Used on instruments and implant components where biocompatibility and chemical stability are required.

• Titanium Aluminum Nitride (TiAlN): High-temperature oxidation resistance. Used on instruments subjected to repeated autoclave cycles.

• Diamond-Like Carbon (DLC): Amorphous carbon coating with exceptional hardness, low friction, and chemical inertness. Used on orthopedic implants, cardiovascular devices, and high-wear articulating surfaces. DLC can be doped with elements to modify properties.

• Antimicrobial coatings: Silver-doped titanium nitride (TiN-Ag) coatings have demonstrated Log 3 reduction against Staphylococcus aureus and MRSA while maintaining functional properties through 50 autoclave cycles. These are gaining traction in trauma applications where surgical site infection risk is high.

PVD coatings are typically 1–5 µm thick. They follow the underlying surface topography — if the substrate has a high Ra, the coated surface will also have high Ra. This means surface finish specification before coating is critical to coating performance after coating.

PVD is a clean, vacuum-based process with no liquid chemicals, making it environmentally preferable to electroplating. The process is performed at moderate temperatures (200–500°C), which limits its applicability on temperature-sensitive substrates.

Electroplating

Electroplating deposits a metal layer from an electrolyte solution onto a conductive substrate. Common medical plating includes gold plating on electrical contacts, nickel plating on instrument bodies, and chromium plating on worn surfaces.

Electroplating is less common than PVD for new medical device designs due to environmental concerns (hexavalent chromium, cyanide-based baths) and variable performance. However, legacy devices still use electroplated surfaces, and the supplier qualification requirements are similar.

Electroplating adds thickness that must be dimensionally planned. The thickness distribution across a part depends on current density, which varies with part geometry — edges and protrusions receive thicker deposits than recesses.

Plasma and Surface Activation Treatments

Plasma treatments modify surface energy without adding a coating. They are used to improve adhesive bonding (increasing surface energy before adhesive application), improve wettability for coatings, or create antimicrobial surface textures on the nanoscale.

Plasma treatment effects are temporary — surface energy decays over hours to days as the surface re-contaminates or reorients. The qualification of a plasma treatment supplier must address the treatment-to-use window.

Antimicrobial and Hydrophilic Coatings

Specialty functional coatings include antimicrobial coatings (silver-ion, copper, or antibiotic-impregnated), hydrophilic coatings (polyvinylpyrrolidone, polyethylene glycol) for catheters and guidewires, and hydrophobic coatings for repelling blood and tissue.

These coatings are application-specific and often proprietary. Their qualification is more complex because their performance depends on the interaction between the coating, the substrate, the application method, and the sterilization process.

Supplier Qualification

Initial Assessment

Not every coating supplier is equipped to serve the medical device industry. The initial assessment should evaluate:

Quality system certification: ISO 13485 certification is the strongest signal that the supplier understands medical device quality requirements. ISO 9001 is a minimum, but it does not address the specific requirements of Clause 7.5.6 (process validation) or Clause 7.4 (purchasing controls) in a medical device context. Some coating suppliers hold both.

Regulatory awareness: Does the supplier understand that the coating process is a special process? Do they have experience supporting IQ/OQ/PQ validation? Can they provide validation support documentation (process parameter records, material traceability, measurement data)?

Facility and equipment: Visit the facility. Assess equipment condition, calibration status, process controls, environmental conditions, and housekeeping. For PVD coatings, evaluate chamber condition, vacuum system maintenance, and source material handling. For passivation, evaluate bath chemistry control, bath life management, and waste handling.

Traceability capability: Can the supplier trace every coated lot back to the specific process run, including date, operator, equipment, parameters, and bath or chamber lot? This is a regulatory requirement under both QMSR and EU MDR.

Capacity and lead time: Evaluate whether the supplier has the capacity to support your current and projected volumes without creating bottlenecks. Assess lead times for both routine and urgent orders.

Financial stability and business continuity: A coating supplier going out of business mid-production is a supply chain emergency. Evaluate financial stability, ownership structure, and business continuity plans.

Audit Focus Areas

A supplier audit for a coating or surface treatment supplier should focus on:

1. Incoming inspection: How does the supplier verify the parts they receive from you? What dimensions, surface conditions, and material certifications do they check?

2. Process control: What are the defined process parameters? How are they monitored and recorded? What happens when parameters drift out of range?

3. Bath or chamber management: For chemical processes, how are bath chemistry, temperature, and contamination monitored? How is bath life tracked, and what triggers bath replacement? For PVD, how is chamber cleanliness maintained between runs?

4. Racking and fixturing: How are parts held during the coating process? Racking affects coating uniformity, thickness distribution, and the presence of contact marks on critical surfaces. Verify that the supplier's fixturing approach is compatible with your part geometry and cosmetic requirements.

5. Measurement capability: What does the supplier measure after coating? Thickness (by XRF, cross-section, or eddy current), adhesion (cross-hatch, pull-off), appearance, and color (for dyed anodize). Are their measurement instruments calibrated? Do they have validated test methods?

6. Nonconformance handling: How does the supplier handle parts that fail coating? Do they strip and re-coat, or scrap? What is the disposition process, and who authorizes it?

7. Change notification: What is the supplier's process for notifying you of changes to their process, equipment, materials, or sub-suppliers? This should be contractually defined in the quality agreement.

Recommended Reading

CDMO Quality Agreement RACI for Sub-Tier Suppliers: Defining Accountability Across the Supply Chain

Quality Systems Supply Chain2026-05-11 · 13 min read

Specification Development

What to Put on the Drawing

A common mistake is putting insufficient specification on the drawing and relying on the coating supplier to determine process parameters. The drawing should specify:

• The coating type (e.g., "Titanium Nitride PVD per AMS 2444" or "Passivation per ASTM A967, Method 2, Citric 2")
• The required thickness or thickness range
• Acceptable thickness measurement method and location
• Required adhesion performance (cross-hatch per ASTM D3359, pull-off per ASTM D4541, or specific to the coating type)
• Surface roughness requirements before and/or after coating
• Dimensional requirements after coating (critical features that must meet drawing tolerance post-coating)
• Cosmetic requirements (color, uniformity, allowable defects)
• Any prohibited areas (masking requirements)
• Required certifications and test reports with each lot

Dimensional Planning

Coatings that add thickness (anodizing, electroplating, PVD to a lesser extent) require dimensional planning. The approach is:

• Identify critical dimensions that will be affected by the coating
• Specify pre-coating dimensions that account for coating thickness growth
• Require the supplier to provide a process plan that achieves final dimensions post-coating
• For tight-tolerance features, specify that final dimensions are verified after coating

For coatings that do not add meaningful thickness (passivation, plasma treatment), verify that the process does not attack precision surfaces. Specify which surfaces must be protected if the treatment is aggressive.

Acceptance Criteria

Define clear acceptance criteria for each coating attribute:

• Thickness: Minimum, maximum, or range. Measured by XRF (non-destructive), cross-section (destructive), eddy current, or micrometer (before/after difference).
• Adhesion: Cross-hatch test (ASTM D3359, Rating 4B or 5B typically required), pull-off test (ASTM D4541), or coating-specific tests (ASTM F1044 for porous coatings on implants).
• Visual appearance: Color match, uniformity, no blistering, no bare spots on functional surfaces, no excessive contact marks from racking.
• Functional testing: Corrosion resistance (salt spray per ASTM B117, or water immersion per ASTM A967), wear resistance, friction coefficient.
• Biocompatibility status: If the coated device requires ISO 10993 testing, confirm that the validated coating process produces a surface that matches the tested configuration.

Process Validation

Who Owns the Validation

The regulatory responsibility for process validation belongs to the OEM. The coating supplier executes the process, but the OEM must approve the validation protocol, review the results, and maintain the validation documentation in the DHF/DMR.

In practice, the coating supplier often drafts the validation protocol (they know their process parameters better than anyone), but the OEM reviews and approves it. The quality agreement should explicitly state that the OEM approves validation protocols and reports.

IQ for Coatings

IQ verifies that the coating equipment is installed correctly and operates within specification:

• Equipment identification (make, model, serial number)
• Calibration verification for temperature sensors, timers, bath chemistry analyzers, power supplies, vacuum gauges
• Chamber or bath mapping (temperature uniformity, coating thickness uniformity across the chamber)
• Verification of fixture and racking configurations
• Software validation for automated process controls (per ISO 13485 Clause 4.1.6 or FDA guidance on process validation software)

OQ for Coatings

OQ establishes the operating parameter windows:

• Process parameter limits (temperature range, time range, concentration range for chemical processes; power, pressure, gas flow, and time for PVD)
• Load configuration studies (maximum and minimum part density, effect on coating uniformity)
• Worst-case parameter combinations
• Multiple operators (if the process is operator-dependent)

OQ acceptance criteria typically include coating thickness, adhesion, and visual appearance at each parameter extreme.

PQ for Coatings

PQ demonstrates consistency over production runs:

• Three consecutive runs (minimum) at nominal parameters
• Each run with a full production load
• Coating thickness, adhesion, and visual inspection on a defined sample size from each run
• Statistical analysis demonstrating process capability

Validation Support from the Supplier

A capable coating supplier will provide:

• Detailed process parameter records for each validation run
• Material and additive traceability
• Measurement data for coating output
• Lot-specific records that support PQ testing
• Process expertise to help define the validation protocol

This support reduces workload for OEM quality teams and ensures coating processes meet regulatory expectations.

Biocompatibility and Regulatory Evidence

The Coating in the Biocompatibility Package

The coating is part of the finished device and must be included in the ISO 10993 biological evaluation. This means:

• The coating material itself must be identified and its toxicological profile assessed
• The coated device must be tested (or justified) for the applicable ISO 10993 endpoints based on body contact type and duration
• Any change to the coating process that could affect the chemical composition or extractables profile of the coated surface may trigger re-evaluation

PVD coatings (TiN, CrN, DLC) generally have favorable biocompatibility profiles because the coating materials (titanium, chromium, carbon) form stable, inert compounds. However, the coating process can introduce trace contaminants or intermetallic phases that affect biological response. Validation must ensure that the validated process produces a coating consistent with the tested configuration.

Passivation is a surface cleaning and oxide formation process that improves biocompatibility by removing allergenic free iron. It is typically not a biocompatibility concern itself, but inadequate passivation (leaving free iron on the surface) is.

Coating Evidence in Regulatory Submissions

For FDA submissions (510(k), PMA, De Novo), the coating process and its validation are part of the manufacturing process description. The FDA expects to see:

• Identification of the coating as a special process
• Summary of the validation approach (IQ/OQ/PQ)
• Acceptance criteria and test methods
• Biocompatibility data for the coated device

For EU MDR CE marking, the Notified Body will review the coating process validation as part of the technical documentation audit and the QMS audit. EU MDR Annex I Section 17.2 requires demonstration that device characteristics are not adversely affected by the manufacturing process.

Recommended Reading

Biological Specimen Raw Material Sourcing for IVD Development: Human Serum, Plasma, and Matrix Materials

Manufacturing IVD & Diagnostics2026-05-11 · 21 min read

Quality Agreement Structure

The quality agreement with a coating supplier must address:

Process definition: What coating process is being performed, to what specification, with what parameters. Reference the specific ASTM, AMS, or internal specification.

Validation ownership: Who drafts, reviews, approves, and maintains the validation documentation.

Change notification: The supplier must notify the OEM before any change to process parameters, equipment, materials, sub-suppliers, or facility location. The OEM then evaluates the change for its impact on validation status.

Lot traceability: The supplier must maintain records that allow traceability from coated lot back to process run, parameters, materials, and operators.

Acceptance criteria and certification: What the supplier tests and reports with each lot. Typically includes thickness measurement, adhesion test, and visual inspection results.

Nonconformance handling: How the supplier handles failed parts, including notification to the OEM and disposition authorization.

Right to audit: The OEM retains the right to audit the supplier's facility and records. This should include unannounced audit rights where justified by risk.

Annual review: Define the frequency of supplier performance review, including on-time delivery, rejection rate, audit findings, and CAPA status.

Ongoing Monitoring

Incoming Inspection

Define what the OEM verifies upon receiving coated parts:

• Certification review (thickness, adhesion, visual results)
• Dimensional verification of critical features post-coating
• Visual inspection of cosmetic surfaces
• Periodic destructive testing (cross-section for thickness verification, adhesion testing)

Supplier Scorecard

Track the coating supplier on:

• On-time delivery
• Lot rejection rate (scrap and rework)
• First-pass yield
• Audit finding closure rate
• Change notification compliance

Periodic Revalidation

Schedule periodic revalidation (typically annually or biennially) to confirm that the validated process remains in control. This is especially important for chemical processes where bath aging can gradually shift process capability.

Common Pitfalls

Insufficient specification on the drawing: "Passivate per ASTM A967" without specifying the method class, corrosion test requirements, or which surfaces are critical leads to inconsistent results. The more specific the specification, the more consistent the output.

Not accounting for dimensional impact: Anodizing adds thickness. PVD adds less, but on tight-tolerance features, even 2–3 µm matters. Define pre-coating dimensions explicitly.

Treating coating as a commodity: Sending parts to the cheapest supplier without auditing their process controls, measurement capability, or quality system leads to inconsistent coating performance and regulatory exposure.

Not validating the coating process: Because the coating supplier performs the process off-site, some OEMs assume the supplier's process qualification is sufficient. It is not. The OEM must validate that the process produces the specified coating on their specific parts. The supplier's IQQ/PQ on test coupons does not demonstrate that your parts come out correctly.

Ignoring surface roughness before coating: Coatings follow the substrate. A PVD coating on a rough surface is a rough PVD coating. If you need low friction post-coating, specify the pre-coat surface finish.

Not monitoring bath or chamber aging: Chemical baths degrade over time. PVD chambers accumulate buildup. The coating that was perfect in validation lot 1 may drift by lot 50. Monitor and maintain.